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Abstract 
Along with the rise in obesity, rates of non-alcoholic fatty liver disease (NAFLD) have also 
increased. NAFLD may begin with fat accumulation in the liver, but can progress to non-
alcoholic steatohepatitis (NASH), fibrosis, and eventual cirrhosis. With no pharmacological 
treatment for NASH, lifestyle interventions appear vital to maintaining liver health. Previous 
work has shown aberrant mitochondrial content/quality and autophagy in models of NAFLD. 
Exercise is known to improve mitochondrial health and possibly autophagy, thus autophagy may 
be a key regulatory factor for treatment of obesity induced-NAFLD. PURPOSE: The purpose of 
the study was to examine how weight loss from diet or diet combined with physical activity 
impacts hepatic mitochondrial content, autophagy and mitochondrial autophagy (mitophagy) in 
NAFLD. METHODS: 48 Male C57BL/6J mice were divided into 1 of 4 groups: low fat diet 
(LFD, 10% fat, 18 wks), high fat diet (HFD, 60% fat diet, 18 wks.), weight loss by diet (D, 60% 
fat diet for 10 wks then 10% fat diet for 8 wks) or weight loss by diet and physical activity 
(D/PA, 60% fat diet for 10 wks, then 10% fat diet plus a running wheel for 8 wks). After 
interventions, livers were collected and analyzed via Western blot for markers of mitochondrial 
content and autophagy. Results were analyzed by one-way ANOVA with α set at 0.05. 
RESULTS:  COX-IV and PGC-1α protein contents were approximately 50% less in HFD 
compared to LFD, and were restored and increased with D/PA, respectively. BNIP3 content was 
45% lower in HFD compared to LFD; D/PA had 50% more BNIP3 compared to LFD controls. 
PINK1 content was 40% higher in D and D/PA animals compared to LFD. P-PARKIN/PARKIN 
levels were 40% lower in HFD, D, and D/PA compared to LFD. Whereas p-UbSer65 was 3-fold 
higher in HFD animals. LC3II/I ratio was 50% greater in HFD and D/PA animals, yet p62 
protein content was 2.5 fold higher in HFD animals compared to LFD, D, and D/PA, with no 
 
 
further differences observed. CONCLUSION: High-fat diet causes disruptions in mitochondrial 
content, mitophagy and macroautophagy. Diet combined with physical activity are able to 
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Non-alcoholic fatty liver disease (NAFLD) is currently the most prominent preventable 
liver ailment in Western society. Rates of NAFLD have closely mirrored the obesity epidemic, 
with an estimated 19-30% of adults in Western society diagnosed with NAFLD (10, 60). 
NAFLD can begin with relatively benign fat accumulation within the liver, but with continual 
lipid overload, can progress to steatosis, inflammation, non-alcoholic steatohepatitis (NASH), 
fibrosis, cirrhosis and potentially carcinoma (59). Currently, there are no effective 
pharmacological interventions for liver disease once progressed to NASH (19) and lifestyle 
interventions to treat symptoms are the most common treatment option. As such, it is imperative 
to understand the physiological mechanisms of lifestyle interventions to halt the progression of 
NAFLD and subsequent NASH. It is currently understood that lifestyle interventions such as diet 
and exercise mitigate many of the symptoms associated with NAFLD. Diet or physical activity 
can decrease fat accumulation (90), but exercise appears to offer additional benefits such as 
increased oxidative metabolism (2, 90) and decreased de novo lipogenesis (90) in mice. These 
findings have been confirmed in human research studies (8).  
 Mitochondria, the major supplier of ATP to the cell, play a major role in the progression 
of NAFLD. Previous work has demonstrated derangements in mitochondrial quality control 
mechanisms in various models of NAFLD (21, 23, 58, 106). Furthermore, work by Rector et al. 
(89) has also demonstrated mitochondrial dysfunction preceding hepatic steatosis in a genetic 
model of NAFLD.  In addition to being important in oxidative metabolism, mitochondrial quality 
also plays a major role in regulation of autophagy.  
Autophagy is a cellular degradation process serving to remove damaged proteins and 
organelles (63). Damaged cellular components are engulfed in a cellular autophagosome, fuse 
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with a lysosome, and are degraded through a lysosomal reaction (63). Disruptions in autophagy 
can result in the accumulation of damaged cellular by-products (24) or cellular apoptosis (83). 
Autophagy disruptions have been implicated in multiple diseases such as cancer cachexia and 
neurological disorders (33). Previous work has demonstrated decreases in autophagy flux (7, 24) 
in murine models of NAFLD. In muscle, it has been shown that exercise increases markers of 
autophagy and is necessary for exercise-training adaptations (67). 
Mitochondria play an important role in the regulation of autophagy, specifically, shuttling 
lipid from the mitochondrial membrane for the formation of the autophagosome (92). 
Additionally, mitochondria also undergo a specific type of autophagy, hereafter referred to as 
mitophagy. Mitochondria undergo multiple mitophagy pathways, with the two predominant 
pathways including: BNIP3 mediated and PINK1/PARKIN mediated mitophagy. BNIP3 
mitophagy predominantly occurs under hypoxic conditions (30, 76), with dysfunctional 
mitochondria being tagged by BNIP3 and shuttled to an LC3 tagged autophagosome (30, 76). 
Knockout of BNIP3, a protein necessary for hypoxia-induced mitophagy, resulted in steatosis in 
mice fed a normal chow diet (23). PINK1/PARKIN mediated mitophagy was first researched in 
genetically inherited Parkinson’s disease (17, 40). Although a relatively new cellular mechanism, 
PINK1/PARKIN mitophagy occurs in instances of mitochondrial depolarization (41, 45, 55), 
with accumulation of PINK1 causing subsequent phosphorylation of PARKIN and ubiquitin, 
tagging the mitochondria for degradation (41, 45, 55). To our knowledge no studies to date have 
investigated hepatic PINK1/PARKIN mitophagy during lipid-overload or exercised conditions. 
Previous work from our laboratory has suggested increased hepatic autophagy with 
exercise may provide protective effects from NAFLD despite lipid overload (unpublished 
findings). Yet it is unclear whether increased autophagy from exercise can fully rescue 
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maladaptations from prolonged high fat diet in NAFLD. Furthermore, it is unclear what, if any 
impact PINK1/PARKIN mitophagy has on hepatic health in NAFLD and with weight loss 
interventions to improve NAFLD. Therefore, the purpose of the study is to investigate autophagy 
and mitophagy regulation after diet or diet combined with physical activity in a murine model of 
NAFLD. 
  4 
Review of Literature 
Obesity has reached pandemic levels in the Western world (77). Pathological 
manifestations as a result of obesity have also dramatically increased, specifically the 
development of fatty liver (4). Nonalcoholic fatty liver disease (NAFLD) has recently become 
one of the most common liver ailments (4, 99), and the most common cause of serious liver 
disease and transplants (93). Lipid overload in the diet along with a sedentary lifestyle result in 
fat accumulation in the liver (71). Fatty liver can progress to impaired liver function (NAFLD), 
hepatic inflammation, steatosis, non-alcoholic steatohepatitis (NASH) and potentially fibrosis 
and cirrhosis.  Currently, there are no pharmacological agents for fatty liver once escalated to 
NASH, as such, it is imperative to prevent liver disease before steatosis has developed. With no 
effective pharmacological interventions, lifestyle alterations have become the common 
recommendation for those afflicted with NAFLD or NASH (14). While it is overall understood 
that lifestyle interventions positively affect the prognosis of those with fatty liver, the 
physiological mechanisms contributing to the initial disease development and lifestyle based 
alleviations are not completely understood. As lifestyle interventions are currently the most 
effective known therapies in NAFLD, they can be utilized to determine potential mechanistic 
targets in the treatment of such conditions. One particular cellular mechanism of interest is the 
cell’s ability to degrade macromolecules, known as autophagy. 
Autophagy serves as the garbage disposal system of the cell, degrading and removing 
damaged proteins and organelles (63). Through a highly conserved signaling process, damaged 
organelles are encased in an autophagosome and subsequently degraded via lysosomal reactions. 
In various pathological conditions it is well established that the autophagy process is negatively 
affected. For example, in some cancers overactive autophagy may contribute to cancer-cachexia 
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(83).  Ischemia-reperfusion injury causes major increases in hepatic autophagy, leading to 
increased cytotoxicity (28) and further exacerbation of liver damage. With regards to NAFLD, 
the significance of autophagy on disease progression and alleviation with respect to lifestyle 
interventions are not yet completely understood. As such, the purpose of this review is to 
examine hepatic autophagy models and mechanisms in NAFLD and the potential efficacy of 
lifestyle interventions in correcting derangements in hepatic autophagy.  
 
Autophagy Regulation 
 Autophagy is a tightly regulated process mediated through the action and interaction of 
many autophagy related genes (Atgs). Autophagy related gene-6, Atg6 (also known as and 
hereafter referred to as Beclin), forms a complex with other Atgs to begin formation of the 
phagophore and ultimately the autophagosome that encompasses proteins or organelles to be 
destroyed (80). Atg7 as well as other Atgs facilitates autophagosome formation and starvation-
induced degradation of proteins (54, 92). Additionally, microtubule-associated protein (MAP) 
light chain 3 (LC3), a subunit of MAP1, also assists with autophagosome formation. LC3 is 
utilized as a signaling protein to bring proteins to the autophagosome (72). First examined in 
neurons (69),  LC3 has two primary conformations, mainly LC3-I and LC3-II.  During the 
autophagy process, LC3-I, located in the cytosol of the cell, undergoes a conformational change 
via reactions with E1- and E2-ligases enzymes to transform into LC3-II (56). LC3-II is bonded to 
a phosphatidylethanolamine and attaches to the outer autophagosomal membrane (56).  
Therefore, the ratio of LC3II/I content can be measured to demonstrate the rate of 
autophagosome formation, a marker of autophagy flux. Finally, p62 (also known as SQSTM1 
protein) is a cargo protein that serves to shuttle proteins/organelles to the autophagosome and is 
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itself destroyed in the autophagy process and can therefore be utilized to measure the completion 
of the autophagy process (11). p62 is phosphorylated by ULK1 at Ser407 and Ser403, increasing 
its affinity for ubiquitinated proteins (43). p62-tagged proteins bind with LC3II-tagged 
autophagosomes and the proteins are degraded along with p62 (11). As such, the amount of p62 
can be measured to determine the completion of autophagy flux, where greater p62 content 
suggests reduced flux, and less p62 suggests greater flux. This method to interpret autophagy 
flux has been commonly utilized and validated in literature (53).  
 
Autophagy and NAFLD  
Methionine and choline deficient MCD diets as well as high fat diets have been used to 
demonstrate alterations in hepatic autophagy with most studies finding a decrease in hepatic 
autophagy (16, 24, 36, 81, 107), with a few showing increases (68, 101). Other dietary models 
have also been employed to induce NAFLD, such as high sugar diets (7, 18, 44, 62), but only 
one has examined hepatic autophagy, demonstrating aberrant autophagy in rats fed fructose (7). 
Current research suggests that some markers of autophagy machinery, such as Beclin, are not 
affected by either high fat diet nor MCD diet (24). Human studies of NAFLD and autophagy 
have demonstrated an increase in the number of autophagosome vesicles in patients with 
NAFLD (20). Paradoxically in that same study, p62 accumulation correlated with serum alanine 
aminotransferase values and inflammation (20, 24), possibly suggesting that hepatocytes can 
initiate the autophagy process via increased autophagosome formation, but are unable to 
complete the degradation progression.  
In addition to autophagy machinery and flux, other proteins may have dramatic effects on 
the cell’s capacity for autophagy. For example, PPARα has become a topic of interest in 
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autophagy regulation in liver (36, 38, 61). PPARα is known to facilitate fatty acid oxidation, and 
in many models of NAFLD, PPARα content is altered, although some studies have found 
increases (7) and others decreases (42, 88). Interventions increasing PPARα have been shown to 
rescue maladaptations in autophagy in NAFLD.  Ursolic Acid, a PPARα activator has been 
found to alleviate NAFLD in high fat fed mice, at least partially due to an increase in hepatic 
autophagy (36). Other studies have noted increased hepatic autophagy via activation of PPARα, 
which was sufficient to improve liver damage in an acute liver failure model (38). Yet, PPARα 
activation does not appear to be the sole activator of autophagy, as long term depletion of 
PPARα (knockout models) has been shown to attenuate autophagy, but did not completely 
abolish autophagy (61). Taken together, it appears that either fatty acid oxidation and/or 
mediators of fatty acid oxidation play a major role in the cell’s ability to perform autophagy.  
Furthermore, calcium channel derangements have also been associated with autophagy 
detriments. In vitro research has found diet-induced obesity causes increased cytosolic calcium 
levels (82). The increased calcium level disrupts the binding of the autophagosome to the 
lysosome, thus causing accumulation of ubiquitinated proteins (82). Treatment of cells or 
animals with verapamil, a calcium channel blocker, restored autophagy flux and ameliorated 
symptoms of NAFLD such as lipid accumulation and steatohepatitis (82). Taken together, these 
findings suggest autophagy is a multi-faceted process that can be affected by multiple cellular 
components and stimuli, possibly suggesting that promotion of autophagy through various means 
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Autophagy and Lifestyle Interventions  
Lifestyle alterations such as exercise are common recommendations for those with liver 
disease or those with predisposing factors for NAFLD (e.g. obesity). Exercise is known to 
alleviate some of the symptoms of NAFLD with or without weight loss (2, 31, 44, 91). Yet, the 
mechanism for how exercise or diet directly affects hepatic autophagy is still not completely 
understood. Previous work has shown that increases in basal autophagy are necessary for aerobic 
training adaptations in the muscle (67). Interestingly, my preliminary data demonstrates elevated 
basal hepatic autophagy following exercise in mice. These training adaptations occurred in spite 
of lipid overload in Western Diet fed animals, suggesting that exercise may be sufficient to 
promote autophagic clearance of damaged cellular components despite lipid overload.  
Previous work has examined exercise and autophagy in the livers of healthy exercised 
rats, finding no difference between groups in autophagy flux or machinery (9). Another recent 
study noted no increases in hepatic autophagy with exercise training (2), although the exercise 
training protocol was relatively short timeline with only three weeks of exercise training. Both 
studies utilized treadmill training for exercise. As treadmill training has been demonstrated to be 
stressful for mice (3, 6, 15), the stress of the training modality may have masked some potential 
exercise training adaptations. Furthermore, voluntary wheel running has been seen to more 
closely mimic human exercise training adaptations (25) including increased time to fatigue 
during graded exercise and muscle mitochondrial content (85) without the additional stress of 
treadmill running (3, 6). Regardless, the role of hepatic autophagy and exercise has not been 
thoroughly explored in healthy or NAFLD models.  
Various supplements have been examined in relation to NAFLD and autophagy. 
Curcumin, bergamot polyphenol fraction, capsaicin and caffeine have shown promising results in 
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cellular and murine models (42, 64, 81, 97), but thus far have not been extended in humans.  
Pharmacological treatments to induce autophagy have also been investigated with 
pharmacological increase in autophagy sufficient to mitigate liver steatosis (65).  Chang and 
collegues (12) recently found ezetimibe treatment in rats and cells with lipid overload decreased 
phenotypic and genotypic symptoms of NAFLD. Furthermore, this was accompanied with 
increased mRNA content of genes associated with autophagy machinery and increased 
autophagy flux (12).To our knowledge, little research has directly investigated autophagy in 
NAFLD after diet interventions.  Overall, lifestyle interventions to increase hepatic autophagy 
and NAFLD appear to have beneficial effects, and these effects appear to carry over to 
pharmacological treatments, but more research is necessary to substantiate these findings.  
 
Autophagy and Mitochondrial Quality  
Currently, it is generally accepted that poor mitochondrial quality, defined as the 
functionality and health of the mitochondrial network (26), is associated with reduced overall 
health (5, 47). Mitochondrial quality control encompasses the processes of biogenesis, dynamics 
(fusing healthy mitochondria together [fusion] and cleaving off unhealthy mitochondria[fission]), 
and mitochondrial specific autophagy (mitophagy). Prior research in liver has demonstrated 
dysregulation in these processes during pathological conditions, and is correlated with reduced 
mitochondrial health (21, 23, 58). It is generally accepted that mitochondrial dysfunction 
precedes significant changes in fat accumulation and insulin resistance in liver (89, 108).  
Furthermore, detriments in hepatic autophagy can affect the mitochondria’s capacity for 
oxidative phosphorylation. In addition to a measure of macroautophagy flux, p62 is a major 
regulator of transcription of oxidative enzymes and other proteins related to mitochondrial 
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biogenesis (37).  ULK1 can phosphorylate p62, which upon binding with the ubiquitinated 
organelle, is further phosphorylated by mTOR (37). This phosphorylation allows NRF2 to 
translocate to the nucleus and promote transcription of oxidative proteins (37). Therefore, 
dysregulation in the signaling between p62 and NRF2 may result in reduced capacity for 
oxidative phosphorylation and possible increased oxidative stress.  
Reductions in mitochondrial quality have also been associated with concurrent alterations 
in autophagy regulation (102). Preliminary work suggests other aspects of mitochondrial quality 
control (biogenesis, content, fusion and fission) are affected by Western Diet before 
macroautophagy flux detriments occur. Evidence also suggests that some of the lipid utilized for 
the formation of the autophagosomal membrane are shuttled from the mitochondria via action of 
Atg9 (92), and deletion of Atg7 in mice has been found to result in misshaped mitochondria (54). 
Overall, these studies demonstrate that hepatic mitochondrial quality and autophagy are closely 
tied processes, suggesting that alterations in one process will affect the other.   
 
Mitophagy in NAFLD 
Mitophagy is of particular importance for liver health (23, 66, 102).Yet, mitophagy is 
relatively unexplored in NAFLD with only a few studies to our knowledge investigating 
mitophagy and NAFLD (23, 66, 102). All of these studies demonstrated major mitophagy 
disruptions in NAFLD.  One major pathway for mitophagy is the BNIP3/Nix pathway. BNIP3 
and Nix respond to hypoxic cellular conditions to facilitate mitochondrial binding with LC3-
tagged autophagosome (30, 76).  One prior study noted hepatic steatosis and fibrosis in normal 
chow fed mice lacking BNIP3 (23), suggesting BNIP3-mediated mitophagy is necessary for liver 
function. Though research investigating Nix in relation to NAFLD is not currently available, as 
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BNIP3-mediated mitophagy has been shown to be important for hepatic health, Nix in relation to 
NAFLD may provide useful information regarding mitophagy during lipid overload. Our 
laboratory’s preliminary data demonstrates that overall autophagic flux is not altered from 8 
weeks of Western Diet. Yet mitochondrial specific autophagy, measured through BNIP3 protein 
content, did exhibit a marked decrease compared to normal chow fed animals, suggesting 
reduced capacity for BNIP3-mediated mitophagy. Furthermore, it has recently been 
demonstrated that loss of ULK1, a protein responsible for autophagy regulation via mTOR and 
AMPK-mediated pathways, attenuates mitophagy (98). This same study also tied reactive 
oxygen species (ROS) accumulation to decreased mitophagy and the necessity of mitophagy for 
adequate oxidative phosphorylation (98). Taken together, these studies suggest mitochondrial 
quality, autophagy, and hepatic health are all tightly related processes.  
In addition to BNIP3-mediated mitophagy, another predominant mitophagy pathway is 
PTEN-induced putative kinase 1 (PINK1)/PARKIN-mediated mitophagy. The PINK1/PARKIN 
pathway was first described in neurological diseases, specifically genetically inherited 
Parkinson’s disease (17, 40). PINK1 is a signaling protein that binds with an outer mitochondrial 
membrane receptor TOM (40). Once bound, PINK1 enters the inner mitochondrial matrix to 
undergo a series of cleavages to go from a 64 kDa protein to a 52 kDa protein, after which the 52 
kDa protein is ejected into the cytosol and degraded (40). When the mitochondria becomes 
depolarized, PINK1 does not enter the inner mitochondrial matrix, and instead accumulates on 
the outer mitochondrial membrane (39). The accumulation of PINK1 phosphorylates ubiquitin 
and PARKIN (41, 45, 55) recruiting PARKIN to the outer mitochondrial membrane (74). 
PARKIN induces ubiquitination of proteins on outer mitochondrial membrane proteins (17). The 
ubiquitination causes other autophagy proteins to translocate to the mitochondria such as p62 
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which then goes to the LC3II-tagged autophagosome (72) and completes the general autophagy 
process. Mitophagy via PINK1 and PARKIN causes an increase in mitochondrial fission and a 
decrease in fusion via ubiquitination of MFN1 and 2 and their subsequent degradation (17, 22, 
40, 50). Figure 1 pictorially demonstrates the two primary mitophagy processes. As increased 
mitochondrial fission and fusion have been noted in murine models of NAFLD (21, 106), it is 
possible that the noted disrupted mitochondrial dynamics is attributable to dysfunctional 
mitophagy.  
 However, to our knowledge, no studies to date have investigated the PINK1/PARKIN 
pathway in NAFLD, despite the apparent ties between the two. Although the PINK1/PARKIN 
pathway has been investigated in other liver diseases (50, 51). Hepatitis B causes increases in 
PINK1, PARKIN, and LC3II gene expression, while silencing PARKIN induced apoptosis (50). 
In hepatitis C studies, a similar pattern was seen with increases in PINK1 and PARKIN, while 
silencing PINK1 and PARKIN inhibited progression of the disease (51).  These few studies in 
liver of the PINK1/PARKIN pathway suggest that the pathway may be of critical importance for 
overall liver health.  In the brain, recent studies have demonstrated exercise’s potential to 
increase the tissue’s capacity for mitophagy as evidenced by greater PINK1 content and LC3II/I 
ratios, but without complete resolution of autophagy as evidenced by no changes in PARKIN or 
p62 (70). A recent study in mice brains by Wei et. al (105) suggested that mitophagy alterations 
may be attributable to reactive oxygen species (ROS) causing decreased mitochondrial 
membrane polarization and increased mitophagy via PINK1/PARKIN pathway. In the brains of 
mice fed a 60% high fat diet, decreases in PARKIN were noted that were also correlated with a 
reduction in PGC1-α (48), the major regulator of mitochondrial biogenesis. This may suggest 
that alterations in mitophagy may cause decreases in mitochondrial biogenesis.  In human 
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exercise studies in muscle acute ultra-endurance exercise elicited no acute changes in mitophagy 
as measured in both the PINK1/PARKIN-mediated pathway as well as BNIP3 pathway, yet did 
illicit alterations in overall autophagy (35). This may be suggestive that alterations in mitophagy 
are long-term effects and not seen acutely. Taken together these studies suggest that mitophagy 
may play a major role in overall cellular health, however the extent that mitophagy affects, or is 
affected by, stimuli such as hepatic lipid overload (NAFLD) or exercise remains elusive.  
 
Summary  
 Autophagy is a cellular degradation process necessary for liver health. NAFLD causes 
disturbances in hepatic autophagy via the inhibition or activation of various cellular signaling 
mechanisms. Lifestyle interventions can ameliorate symptoms of NAFLD, specifically with 
regard to autophagy, although the specific mechanisms are not completely understood. It is 
currently not well known how mitophagy is related to NAFLD or if activation of mitophagy by 
lifestyle interventions is sufficient to rescue maladaptations associated with NAFLD. Therefore 
future research should seek to investigate the mechanism of autophagy and mitophagy 
derangements in NAFLD and how these mechanisms are altered with diet or exercise.  
 
Purpose 
The purpose of this study is to examine autophagy and mitophagy regulation in high fat 








Animal Interventions  
 All animal work was performed at and approved by the Southern Illinois University at 
Edwardsville Institutional Animal Care and Use Committee.  48 C57BL/6J (Jackson Laboratories, 
Bar Harbor, ME) mice were evenly divided into two groups at 6 wks of age, one group of 12 
animals consumed low fat diet (LFD, 10% of kcal from fat, Research Diets, New Brunwick, NJ) 
and 36 animals consumed high fat diet to induce obesity (60% of kcal from fat, Research Diets). 
Animals consumed chow for 10 wks, after which, high fat diet-induced obese animals were further 
divided into three groups, one (HFD) continued to consume the 60% high fat diet, one group was 
placed back on the 10% fat diet to induce weight loss (D) and the final group was placed on the 
10% fat diet and given a freely movable running wheel to provide physical activity to induce 
weight loss (D/PA). Wheel running activity was monitored via computer running wheel software. 
LFD animals continued consuming 10% fat chow. Animals continued interventions for an 
additional 8 wks. Final groups included: LFD, HFD, D, D/PA with n=12 in each group (Figure 2). 
After interventions, animals were humanly euthanized, blood and livers collected and snap frozen 
in liquid nitrogen for later analysis. 6 hours before tissue harvest animals’ food was removed; 24 
hours before tissue harvest running wheels were removed from cages of D/PA animals. Liver lipid 
content, blood analysis of triglycerides and cholesterol were assessed as previously described (86). 
 
Isolation of Protein and Immunoblotting  
Isolation of protein and immunoblotting were performed as previously described (26). 
Briefly, 40 mg of liver was homogenized in glass dounce type homogenizers in 0.30 ml of 
complete protein loading buffer (50 mM Tris·HCl, pH 6.8, 1% sodium dodecyl sulfate (SDS), 10% 
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glycerol, 20 mM dithiothreitol, 127 mM 2-mercaptoethanol, and 0.01% bromophenol blue 
supplemented with protease inhibitors (Roche) and phosphatase inhibitors (Sigma-Aldrich, St. 
Louis, MO) according to Alliance for Cellular Signaling protocols and as described elsewhere 
(26). After homogenization, samples were transferred to sterile 1.5mL microcentrifuge tubes, 
heated for 5 minutes at 95°C to denature protein and then centrifuged for 5 minutes at 13,000 rpm.  
Protein concentrations were determined using a commercially available RC/DC assay kit 
following manufacturer instructions (Bio-Rad, Hercules, CA).  40 µg of liver protein were loaded 
into 6-15% SDS-polyacrylamide gels, depending on size of protein of interest, and transferred onto 
PVDF membranes (Thermo Scientific, Rockford, IL, USA). Membranes were blocked for an hour 
in 5% milk solution in 0.5% TBST, and then incubated in primary antibody blocking solution at 
4°C. After 12-48 hour primary incubation, membranes were washed in 0.5% TBST and incubated 
with appropriate secondary antibody solutions for 1 hour (Li-Cor Biosciences, Lincoln, NE). 
Membranes were imaged using a FlourChem M (Protein Simple, San Jose, CA) and protein 
content normalized to Ponceau S. Primary antibodies included: COX-IV, p62/SQSTM1, LC3A/B, 
BNIP3, PINK1, PARKIN, P-PARKIN-S65, Ubiquitin, and  P-Ubiquitin-S65.  
 
Statistical Analysis  
Independent variables were intervention (LFD v. HFD v. D v. D/PA). Results were 
analyzed by one-way analysis of variance (ANOVA), with α set at 0.05. Duncan’s multiple range 
test was used to distinguish differences among means. All data were analyzed using the Statistical 
Analysis System (SAS, version 9.3, Cary, NC) and expressed as mean ± SEM. 
 
 




HFD resulted in NAFLD phenotype, weight loss interventions ameliorated many phenotypic 
symptoms of NAFLD  
 HFD animals were approximately 50% heavier compared to LFD or D animals (Figure 
3A, p<0.05). D restored body weights to LFD levels (Figure 3A, p>0.05). D/PA animals were 
approximately 4 grams lighter compared to LFD or D animals (Figure 3A, p<0.05). Liver 
weights followed a similar pattern, with HFD liver weights about 2-fold greater than LFD, D, or 
D/PA (Figure 3B, p<0.05).HFD and D/PA animals consumed approximately 30% more calories 
compared to LFD and D during the last 8 wks of protocol (Figure 3C, p<0.05). By weight, D/PA 
animals consumed approximately 25% more food compared to the other three groups during the 
last 8 wks of protocol (Figure 3D, p<0.05). D/PA animals ran approximately 8.8 + 0.1 km per 
day.  Liver lipid content was slightly more than 2-fold greater in HFD compared to LFD animals, 
and more than 5-fold greater compared to D and D/PA (Figure 3E, p<0.05). HFD resulted in 
over 2-fold increase in hepatic triglyceride levels compared to LFD (Figure 3F, p<0.05). D as 
well as D/PA caused lower levels of triglycerides compared to LFD, with D/PA having slightly 
reduced levels compared to D (Figure 3F, p<0.05). HFD animals had approximately 30% greater 
hepatic cholesterol levels compared to LFD (Figure 3G, p<0.05), while D was not different from 
either HFD or LFD (Figure 3G, p>0.05). D/PA resulted in 60% lower cholesterol levels 
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Mitochondrial content and biogenesis markers were negatively affected by HFD, weight loss 
interventions rescued some of these maladaptations  
 COX-IV content, a common surrogate marker of mitochondrial content (26, 27), was   
approximately 50% lower in HFD compared to LFD animals (Figure 4A, p<0.05). COX-IV 
content in D animals was not different from either LFD or HFD (Figure 4A, p>0.05). D/PA 
restored COX-IV content, with no difference between D/PA and LFD (Figure 4A, p>0.05). 
Protein content of PGC1-α was 50% lower in HFD animals compared to LFD animals (Figure 
4B, p<0.05). D restored PGC1-α levels with no difference between LFD and D (Figure 3B, 
p>0.05). D/PA animal had approximately 50% more PGC1-α compared to LFD animals (Figure 
4B, p<0.05). 
 
BNIP3 mediated autophagy was impaired by HFD and enhanced by D/PA  
 BNIP3 protein content was 45% lower in HFD animals compared to LFD animals 
(Figure 5A, p<0.05). D was not different from LFD or HFD (p>0.05), whereas D/PA had about 
50% greater content compared to LFD (Figure 5A, p<0.05).  
 
PINK1/PARKIN-mediated mitophagy was altered at different regulatory points in all three 
experimental conditions 
 PINK1 protein content was unaffected by HFD (p>0.05), whereas, D and D/PA each 
resulted in approximately 40% greater PINK1 compared to LFD (Figure 6A, p<0.05). PARKIN 
content was 4-fold greater in D animals compared to LFD (Figure 6B, p<0.05). Whereas, 
PARKIN content in HFD and D/PA did not differ from LFD (Figure 6B, p>0.05). With regards 
to p-PARKINSer65 no interventions were statistically different from LFD, although, D was 
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approximately 50% lower compared to HFD and D/PA (Figure 6C, p<0.05). Comparing p-
PARKINSer65/PARKIN ratios, all three experimental groups (HFD, D, and D/PA) were roughly 
40% lower compared to LFD (Figure 6D, p<0.05). Total Ubiquitin protein content was 
unaffected by HFD compared to LFD (Figure 6E, p>0.05). D and D/PA had about 50% greater 
ubiquitin content compared to HFD (p<0.05), but only D was statistically different from LFD 
(Figure 5E, p<0.05). p-UbiquitinSer65 was 2.5 times greater in HFD compared to LFD, D, and 
D/PA (Figure 6F, p<0.05), with no other differences noted between groups. p-
UbiquitinSer65/Ubiquitin was 3-fold greater  in HFD animals compared to the three other 
experimental groups (Figure 6G, p<0.05), with no other differences between groups. 
 
Macroautophagy flux was decreased in HFD animals and rescued with weight loss interventions  
 As LC3I is lipidated into LC3II to become a part of the autophagosome membrane, the 
ratio of LC3II/I can be utilized to determine the rate of autophagosome formation (53). This 
methodology is commonly utilized to analyze autophagy membrane formation and has been 
validated by Klionsky et al. in murine models (52), LC3II/I ratio was approximately 2-fold 
greater in HFD and D/PA animals compared to LFD (Figure 6A, p<0.05). D was not different 
from LFD (Figure 6A, p>0.05). LC3II content was approximately 100% greater in D/PA 
compared to LFD and D animals (Figure 7B, p<0.05), although HFD was not statically different 
from any of the three other groups (Figure 7B, p>0.05). Total LC3, found by adding the density 
of both the LC3I and LC3II bands, was 2-fold greater in D/PA animals compared to LFD, HFD, 
and D (Figure 7C, p<0.05), with no further differences noted in the other three experimental 
groups. Since p62 is taken into the autophagosome along with the organelle or protein to be 
degraded, the amount of p62 protein content can by utilized as a measure of autophagy 
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resolution, with greater p62 content indicative of reduced autophagy flux and reduced p62 
indicative of greater autophagy flux (52). p62 content was 2.5-fold greater in HFD compared to 
LFD, D, or D/PA (Figure 7D, p<0.05), there were no other differences between groups.  
 
AMPK activity was unaffected by interventions 
 AMPK acts as a major regulator of autophagy initiation by activating ULK1 (49) , 
therefore we sought to determine if changes in AMPK activity could explain noted differences 
between groups. Total AMPK content was unaffected by HFD compared to LFD, D was 
approximately 50% greater compared to HFD (p<0.05), but no other differences were noted 
between interventions (Figure 8A, p>0.05). Neither p-AMPKThr172  or p-AMPK/AMPK content 

















 To our knowledge, our group is the first to report on PINK1/PARKIN-mediated 
mitophagy in high-fat diet-induced NAFLD in addition to utilizing weight loss interventions to 
lessen NAFLD symptoms. Our results demonstrate concurrent diet and physical activity provides 
greater benefits on aspects of mitochondrial biogenesis and content compared to diet alone as a 
treatment for NAFLD. Furthermore, D/PA appears to provide benefits on autophagy and 
mitophagy, whereas diet does not appear to have as prominent effects with regard to mitophagy. 
Our results suggest that in NAFLD hepatocytes may forgo mitophagy in efforts to maintain 
mitochondria albeit likely dysfunctional, which may increase liver susceptibility to progression 
of fatty liver disease into more serious conditions.  
 First, our high fat diet was sufficient to induce NAFLD, similar to previous research (13, 
84, 89, 90), demonstrating increased body weight, liver weight, circulating triglycerides, and 
cholesterol levels. D and D/PA rescued most of these phenotypic maladaptations. Our data 
follows our previous findings with reductions in PGC1-α content (unpublished findings). 
Although diet was sufficient to rescue PGC1-α content, it was not sufficient to restore COX-IV 
content. Contrastingly, D/PA increased PGC1-α content above baseline and completely restored 
mitochondrial content as measured by COX-IV. While PGC1-α content does not specifically 
measure mitochondrial biogenesis, as the major regulator of mitochondrial biogenesis (87), 
PGC1-α content provides valuable insight into promotion of mitochondrial biogenesis in this 
model. Additionally, previous studies have corroborated our findings of reduced mitochondrial 
biogenesis and content in NAFLD utilizing multiple methods (1, 58, 84). Taken together, these 
data demonstrate diet combined with physical activity are more effective for treating disrupted 
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hepatic mitochondrial biogenesis and content compared to diet alone in murine models of 
NAFLD.  
 HFD severely attenuated the hepatocyte’s capacity for BNIP3-mediated mitophagy, as 
measured by reduced BNIP3 content. This follows our previous observations in pre-NAFLD 
animals (unpublished findings). As directly measuring the mitophagy process was not a viable 
option for this study, we interpret alterations in BNIP3 protein content as reflective of the 
hepatocyte’s capacity for mitophagy. While HFD reduced BNIP3-mitophagy, D was not 
different from either HFD or LFD animals, thus the total impacts of D on BNIP3-mediated 
mitophagy are inconclusive. Yet, D/PA increased BNIP3-mediated mitophagy capacity above 
basal levels (LFD). Our findings align with previous research in murine skeletal muscle 
demonstrating increased mitophagy markers (suggestive of increase mitochondrial turnover) in 
exercised animals (35, 67). Recent reports have also suggested that increased mitophagy is 
necessary for increased mitochondrial biogenesis (34, 96), therefore it is unsurprising that BNIP3 
content mirrored PGC1-α content in exercised animals. Taken together, our findings suggest that 
D/PA is more effective in restoring BNIP3-mediated mitophagy compared to D alone.  
 Interestingly, while BNIP3 is suppressed in HFD and increased in D/PA animals, the 
PINK1/PARKIN pathway is not as easily interpreted. While D or D/PA appear to increase 
capacity for mitophagy through this mechanism as evidenced by increased PINK1 content, the 
entire PINK1/PARKIN mitophagy process may be attenuated in HFD, D, and D/PA, as 
evidenced by decreased p-PARKIN/PARKIN content. Yet, p-UbSer65 appears to suggest the 
opposite in HFD animals, with p-UbSer65/Ub ratios greatly increased compared to all other 
groups. The complicated interplay between p-UbSer65, PARKIN and PINK1 is not yet entirely 
understood, but current literature suggests that for optimal activation of PARKIN, PINK1 needs 
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to phosphorylate both ubiquitin and PARKIN at Serine 65 (32). In addition to phosphorylation 
by PINK1, PARKIN is further activated by p-UbSer65 (79, 104). Specifically, p-UbSer65 binds to p-
PARKINSer65 leading to a conformational shift (46, 95, 103), allowing PARKIN to mediate 
ubiquitination of the outer mitochondrial membrane proteins, and tagging the mitochondria for 
degradation (73, 94). Currently, PINK1 is the only known protein to phosphorylate Ubiquitin at 
Ser65, suggesting that p-UbSer65 is specific to PINK1 activity; although it is possible that another 
protein may perform the same function (32, 100). We noted increased p-UbSer65 with a 
concurrent reduction in P-PARKIN/PARKIN ratio. p-UbSer65 is currently known to be 
predominantly utilized for mitophagy (41) and p-UbSer65 binds to PARKIN to trigger E3 ligase 
activity (46, 57, 78). This may suggest that in NAFLD, hepatocytes may attempt to increase 
mitophagy through accumulation of p-UbSer65 in order to dispose of damaged mitochondria 
and/or replace damaged mitochondria with new mitochondria. Yet, due to decreased 
mitochondrial biogenesis, the cell may forgo resolution of PINK1/PARKIN-mediated mitophagy 
in an effort to maintain some of the mitochondrial network, regardless of the mitochondria’s 
functionality. Or there may be some unknown dysfunction in the signaling between p-UbSer65 and 
p-PARKINSer65, resulting in an accumulation of p-UbSer65 without the synchronized increase in p-
PARKINSer65 activity. Correspondingly, mitochondria in D or D/PA animals, although having 
greater capacity for PINK1/PARKIN mitophagy, may forgo PINK1/PARKIN mitophagy in 
favor of BNIP3-mediated mitophagy. Although future research investigating total mitochondrial 
density and function is required to substantiate these claims. We should note that our data are 
collected in a relatively basal state as running wheels were removed 24 hours prior to harvest and 
food removed 6 hours before to remove effects of acute PA and feeding. Considering this we 
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believe our examination is of basal phosphorylation and content of these targets which may 
impact interpretations of the effects of these stimuli.  
 Corroborating some of our mitophagy specific markers, our markers of macroautophagy, 
suggested a slightly greater capacity for autophagosome formation in D/PA animals, as 
evidenced by increased total LC3 content (52). Interestingly, HFD animals had greater LC3II/I 
ratio compared to LFD and D, potentially suggesting enhanced autophagy initiation through 
increased autophagosome formation. Yet HFD had significantly greater p62 levels, compared to 
all other groups, suggesting impaired resolution of autophagy via accumulation of p62. Taken 
together, these markers suggest an attempted increase in macroautophagy flux, but decreased 
resolution in high fat diet-induced NAFLD.  
Maintaining dysfunctional hepatic mitochondria via decreased mitophagy at the BNIP3 
and PINK1/PARKIN levels, may lead to accumulation of reactive oxygen species (ROS). 
Unrestrained ROS production has been associated with decreased liver health (75) and possible 
progression of fatty liver disease (29, 75). Therefore, it is possible that decreased mitophagy 
through high fat diet-induced NAFLD, may be a major regulatory point for progression of 
NAFLD. As such, therapeutics to promote mitophagy in NAFLD, may be possible treatment 
options.  
Taken, together our research demonstrates fluctuating mitophagy responses to HFD-
induced NAFLD as well as weight loss therapeutic interventions. Whereas BNIP3-mediated 
mitophagy appears to be blunted in NAFLD, PINK1/PARKIN mitophagy appears to be induced, 
but not fully resolved in NAFLD. D and D/PA both appear to restore some aspects of 
mito/macroautophagy, with an overall greater effect of D/PA. Increasing autophagy may 
partially ameliorate symptoms of NAFLD, though more research is necessary to substantiate this 
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claim. With no current FDA approved pharmacological methods to specifically target NAFLD, it 
appears lifestyle interventions are the best available option to increase hepatic autophagy and 


























1. Aharoni-Simon M, Hann-Obercyger M, Pen S, Madar Z, Tirosh O. Fatty liver is 
associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial 
biogenesis in mice. Lab Invest. 2011;91(7):1018-28. 
2. Alex S, Boss A, Heerschap A, Kersten S. Exercise training improves liver steatosis in 
mice. Nutr Metab (Lond). 2015;12:29. 
3. Allen JM, Berg Miller ME, Pence BD et al. Voluntary and forced exercise differentially 
alters the gut microbiome in C57BL/6J mice. J Appl Physiol (1985). 2015;118(8):1059-
66. 
4. Almeda-Valdes P, Aguilar-Olivos N, Uribe M, Mendez-Sanchez N. Common Feathers of 
the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. Reviews of Recent 
Clincial Trials. 2014. 
5. Anderson EJ, Lustig ME, Boyle KE et al. Mitochondrial H2O2 emission and cellular 
redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin 
Invest. 2009;119(3):573-81. 
6. Andreev-Andrievskiy AA, Popova AS, Borovik AS et al. Stress-associated 
cardiovascular reaction masks heart rate dependence on physical load in mice. Physiol 
Behav. 2014;132:1-9. 
7. Baena M, Sangüesa G, Hutter N et al. Fructose supplementation impairs rat liver 
autophagy through mTORC activation without inducing endoplasmic reticulum stress. 
Biochim Biophys Acta. 2015;1851(2):107-16. 
8. Balducci S, Cardelli P, Pugliese L et al. Volume-dependent effect of supervised exercise 
training on fatty liver and visceral adiposity index in subjects with type 2 diabetes The 
Italian Diabetes Exercise Study (IDES). Diabetes Res Clin Pract. 2015;109(2):355-63. 
9. Bayod S, Del Valle J, Pelegri C et al. Macroautophagic process was differentially 
modulated by long-term moderate exercise in rat brain and peripheral tissues. J Physiol 
Pharmacol. 2014;65(2):229-39. 
10. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty 
liver disease. Dig Dis. 2010;28(1):155-61. 
11. Bjorkoy G, Lamark T, Pankiv S, Overvatn A, Brech A, Johansen T. Monitoring 
autophagic degradation of p62/SQSTM1. Methods Enzymol. 2009;452:181-97. 
12. Chang E, Kim L, Park SE et al. Ezetimibe improves hepatic steatosis in relation to 
autophagy in obese and diabetic rats. World J Gastroenterol. 2015;21(25):7754-63. 
13. Chen HL, Tung YT, Tsai CL et al. Kefir improves fatty liver syndrome by inhibiting the 
lipogenesis pathway in leptin-deficient ob/ob knockout mice. Int J Obes (Lond). 
2014;38(9):1172-9. 
   26 
 
 
14. Colak Y, Yesil A, Mutlu HH et al. A potential treatment of non-alcoholic fatty liver 
disease with SIRT1 activators. J Gastrointestin Liver Dis. 2014;23(3):311-9. 
15. Cook MD, Martin SA, Williams C et al. Forced treadmill exercise training exacerbates 
inflammation and causes mortality while voluntary wheel training is protective in a 
mouse model of colitis. Brain Behav Immun. 2013;33:46-56. 
16. Das S, Seth RK, Kumar A et al. Purinergic receptor X7 is a key modulator of metabolic 
oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic 
steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2013;305(12):G950-63. 
17. Durcan TM, Fon EA. The three 'P's of mitophagy: PARKIN, PINK1, and post-
translational modifications. Genes Dev. 2015;29(10):989-99. 
18. Fakhoury-Sayegh N, Trak-Smayra V, Khazzaka A et al. Characteristics of nonalcoholic 
fatty liver disease induced in wistar rats following four different diets. Nutr Res Pract. 
2015;9(4):350-7. 
19. Filozof C, Goldstein BJ, Williams RN, Sanyal A. Non-Alcoholic Steatohepatitis: Limited 
Available Treatment Options but Promising Drugs in Development and Recent Progress 
Towards a Regulatory Approval Pathway. Drugs. 2015. 
20. Fukuo Y, Yamashina S, Sonoue H et al. Abnormality of autophagic function and 
cathepsin expression in the liver from patients with non-alcoholic fatty liver disease. 
Hepatol Res. 2014;44(9):1026-36. 
21. Galloway CA LH, Brookes PS, Yoon Y. Decreasing mitochondrial fission alleviates 
hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Am J Physiol 
Gastrointest Liver Physiol. 2014:632-41. 
22. Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH, Taanman JW. Mitofusin 1 and 
mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of 
mitophagy. Hum Mol Genet. 2010;19(24):4861-70. 
23. Glick D, Zhang W, Beaton M et al. BNip3 regulates mitochondrial function and lipid 
metabolism in the liver. Mol Cell Biol. 2012;32(13):2570-84. 
24. González-Rodríguez A, Mayoral R, Agra N et al. Impaired autophagic flux is associated 
with increased endoplasmic reticulum stress during the development of NAFLD. Cell 
Death Dis. 2014;5:e1179. 
25. Greene NP, Fluckey JD, Lambert BS, Greene ES, Riechman SE, Crouse SF. Regulators 
of blood lipids and lipoproteins? PPARδ and AMPK, induced by exercise, are correlated 
with lipids and lipoproteins in overweight/obese men and women. Am J Physiol 
Endocrinol Metab. 2012;303(10):E1212-21. 
26. Greene NP, Lee DE, Brown JL et al. Mitochondrial quality control, driven by PGC-1α, is 
dysregulated by Western Diet-induced obesity and partially restored by moderate 
physical activity in mice. Physiological Reports. 2015;3:e12470. 
   27 
 
 
27. Greene NP NM, Washington TA, Lee DE, Brown LA, Papineau AM, Shimkus KL, 
Greene ES, Crouse SF, Fluckey JD. Impaired exercise-induced mitochondrial biogenesis 
in the obese Zucker rat, despite PGC-1α induction, is due to compromised mitochondrial 
translation elongation. Am J Physiol Endocrinol Metab. 2014:E503-11. 
28. Gupta NA, Kolachala VL, Jiang R et al. Mitigation of autophagy ameliorates 
hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver. 
Am J Physiol Gastrointest Liver Physiol. 2014;307(11):G1088-99. 
29. Gusdon AM, Song KX, Qu S. Nonalcoholic Fatty liver disease: pathogenesis and 
therapeutics from a mitochondria-centric perspective. Oxid Med Cell Longev. 
2014;2014:637027. 
30. Hamacher-Brady A, Brady NR. Mitophagy programs: mechanisms and physiological 
implications of mitochondrial targeting by autophagy. Cell Mol Life Sci. 2015. 
31. Haus JM, Solomon TP, Kelly KR et al. Improved hepatic lipid composition following 
short-term exercise in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 
2013;98(7):E1181-8. 
32. Herhaus L, Dikic I. Expanding the ubiquitin code through post-translational modification. 
EMBO Rep. 2015;16(9):1071-83. 
33. Huang J, Klionsky DJ. Autophagy and human disease. Cell Cycle. 2007;6(15):1837-49. 
34. Ivankovic D, Chau KY, Schapira AH, Gegg ME. Mitochondrial and lysosomal 
biogenesis are activated following PINK1/parkin-mediated mitophagy. J Neurochem. 
2015. 
35. Jamart C, Naslain D, Gilson H, Francaux M. Higher activation of autophagy in skeletal 
muscle of mice during endurance exercise in the fasted state. Am J Physiol Endocrinol 
Metab. 2013;305(8):E964-74. 
36. Jia Y, Kim S, Kim J et al. Ursolic acid improves lipid and glucose metabolism in high-
fat-fed C57BL/6J mice by activating peroxisome proliferator-activated receptor alpha and 
hepatic autophagy. Mol Nutr Food Res. 2015;59(2):344-54. 
37. Jiang T, Harder B, Rojo de la Vega M, Wong PK, Chapman E, Zhang DD. p62 links 
autophagy and Nrf2 signaling. Free Radic Biol Med. 2015;88(Pt B):199-204. 
38. Jiao M, Ren F, Zhou L, Duan Z, Zhao C. [Roles of peroxisome proliferator-activated 
receptor-α in acute liver failure and its pathogenetic mechanism in mice]. Zhonghua Yi 
Xue Za Zhi. 2014;94(26):2059-63. 
39. Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, Youle RJ. Mitochondrial 
membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J 
Cell Biol. 2010;191(5):933-42. 
   28 
 
 
40. Jin SM, Youle RJ. PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci. 
2012;125(Pt 4):795-9. 
41. Kane LA, Lazarou M, Fogel AI et al. PINK1 phosphorylates ubiquitin to activate Parkin 
E3 ubiquitin ligase activity. J Cell Biol. 2014;205(2):143-53. 
42. Kang OH, Kim SB, Seo YS et al. Curcumin decreases oleic acid-induced lipid 
accumulation via AMPK phosphorylation in hepatocarcinoma cells. Eur Rev Med 
Pharmacol Sci. 2013;17(19):2578-86. 
43. Katsuragi Y, Ichimura Y, Komatsu M. p62/SQSTM1 functions as a signaling hub and an 
autophagy adaptor. FEBS J. 2015. 
44. Kawanishi N, Yano H, Mizokami T, Takahashi M, Oyanagi E, Suzuki K. Exercise 
training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet 
induced-obesity in mice. Brain Behav Immun. 2012;26(6):931-41. 
45. Kazlauskaite A, Kondapalli C, Gourlay R et al. Parkin is activated by PINK1-dependent 
phosphorylation of ubiquitin at Ser65. Biochem J. 2014;460(1):127-39. 
46. Kazlauskaite A, Martínez-Torres RJ, Wilkie S et al. Binding to serine 65-phosphorylated 
ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation. 
EMBO Rep. 2015;16(8):939-54. 
47. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human 
skeletal muscle in type 2 diabetes. Diabetes. 2002;51(10):2944-50. 
48. Khang R, Park C, Shin JH. Dysregulation of parkin in the substantia nigra of db/db and 
high-fat diet mice. Neuroscience. 2015;294:182-92. 
49. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through 
direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132-41. 
50. Kim SJ, Khan M, Quan J, Till A, Subramani S, Siddiqui A. Hepatitis B virus disrupts 
mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis. PLoS 
Pathog. 2013;9(12):e1003722. 
51. Kim SJ, Syed GH, Siddiqui A. Hepatitis C virus induces the mitochondrial translocation 
of Parkin and subsequent mitophagy. PLoS Pathog. 2013;9(3):e1003285. 
52. Klionsky DJ, Abdalla FC, Abeliovich H et al. Guidelines for the use and interpretation of 
assays for monitoring autophagy. Autophagy. 2012;8(4):445-544. 
53. Klionsky DJ, Abdelmohsen K, Abe A et al. Guidelines for the use and interpretation of 
assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1-222. 
54. Komatsu M, Waguri S, Ueno T et al. Impairment of starvation-induced and constitutive 
autophagy in Atg7-deficient mice. J Cell Biol. 2005;169(3):425-34. 
   29 
 
 
55. Kondapalli C, Kazlauskaite A, Zhang N et al. PINK1 is activated by mitochondrial 
membrane potential depolarization and stimulates Parkin E3 ligase activity by 
phosphorylating Serine 65. Open Biol. 2012;2(5):120080. 
56. Kouno T, Mizuguchi M, Tanida I et al. Solution structure of microtubule-associated 
protein light chain 3 and identification of its functional subdomains. J Biol Chem. 
2005;280(26):24610-7. 
57. Koyano F, Okatsu K, Kosako H et al. Ubiquitin is phosphorylated by PINK1 to activate 
parkin. Nature. 2014;510(7503):162-6. 
58. Kuo JJ, Chang HH, Tsai TH, Lee TY. Positive effect of curcumin on inflammation and 
mitochondrial dysfunction in obese mice with liver steatosis. Int J Mol Med. 
2012;30(3):673-9. 
59. Lavallard VJ, Gual P. Autophagy and non-alcoholic fatty liver disease. Biomed Res Int. 
2014;2014:120179. 
60. Lazo M, Hernaez R, Eberhardt MS et al. Prevalence of nonalcoholic fatty liver disease in 
the United States: the Third National Health and Nutrition Examination Survey, 1988-
1994. Am J Epidemiol. 2013;178(1):38-45. 
61. Lee JM, Wagner M, Xiao R et al. Nutrient-sensing nuclear receptors coordinate 
autophagy. Nature. 2014;516(7529):112-5. 
62. Lee JS, Jun DW, Kim EK, Jeon HJ, Nam HH, Saeed WK. Histologic and Metabolic 
Derangement in High-Fat, High-Fructose, and Combination Diet Animal Models. 
ScientificWorldJournal. 2015;2015:306326. 
63. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27-
42. 
64. Li Q, Li L, Wang F et al. Dietary capsaicin prevents nonalcoholic fatty liver disease 
through transient receptor potential vanilloid 1-mediated peroxisome proliferator-
activated receptor δ activation. Pflugers Arch. 2013;465(9):1303-16. 
65. Lin CW, Zhang H, Li M et al. Pharmacological promotion of autophagy alleviates 
steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. J 
Hepatol. 2013;58(5):993-9. 
66. Linden MA, Lopez KT, Fletcher JA et al. Combining metformin therapy with caloric 
restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in 
obese rats. Appl Physiol Nutr Metab. 2015;40(10):1038-47. 
67. Lira VA, Okutsu M, Zhang M et al. Autophagy is required for exercise training-induced 
skeletal muscle adaptation and improvement of physical performance. FASEB J. 
2013;27(10):4184-93. 
   30 
 
 
68. Liu K, Lou J, Wen T et al. Depending on the stage of hepatosteatosis, p53 causes 
apoptosis primarily through either DRAM-induced autophagy or BAX. Liver Int. 
2013;33(10):1566-74. 
69. Mann SS, Hammarback JA. Gene localization and developmental expression of light 
chain 3: a common subunit of microtubule-associated protein 1A(MAP1A) and MAP1B. 
J Neurosci Res. 1996;43(5):535-44. 
70. Marques-Aleixo I, Santos-Alves E, Balça MM et al. Physical exercise improves brain 
cortex and cerebellum mitochondrial bioenergetics and alters apoptotic, dynamic and 
auto(mito)phagy markers. Neuroscience. 2015;301:480-95. 
71. Molendi-Coste O, Legry V, Leclercq IA. Dietary lipids and NAFLD: suggestions for 
improved nutrition. Acta Gastroenterol Belg. 2010;73(4):431-6. 
72. Narendra D, Kane LA, Hauser DN, Fearnley IM, Youle RJ. p62/SQSTM1 is required for 
Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for 
both. Autophagy. 2010;6(8):1090-106. 
73. Narendra D, Walker JE, Youle R. Mitochondrial quality control mediated by PINK1 and 
Parkin: links to parkinsonism. Cold Spring Harb Perspect Biol. 2012;4(11). 
74. Narendra DP, Jin SM, Tanaka A et al. PINK1 is selectively stabilized on impaired 
mitochondria to activate Parkin. PLoS Biol. 2010;8(1):e1000298. 
75. Nassir F, Ibdah JA. Role of mitochondria in nonalcoholic fatty liver disease. Int J Mol 
Sci. 2014;15(5):8713-42. 
76. Novak I, Kirkin V, McEwan DG et al. Nix is a selective autophagy receptor for 
mitochondrial clearance. EMBO Rep. 2010;11(1):45-51. 
77. Ogden CL, National Center for Health Statistics CfDCaP, Hyattsville, Maryland, Carroll 
MD et al. Prevalence of Childhood and Adult Obesity in the United States, 2011-2012. 
JAMA. 2015;311(8):806-14. 
78. Ordureau A, Heo JM, Duda DM et al. Defining roles of PARKIN and ubiquitin 
phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement 
strategy. Proc Natl Acad Sci U S A. 2015;112(21):6637-42. 
79. Ordureau A, Sarraf SA, Duda DM et al. Quantitative proteomics reveal a feedforward 
mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol 
Cell. 2014;56(3):360-75. 
80. Otto GP, Wu MY, Kazgan N, Anderson OR, Kessin RH. Dictyostelium macroautophagy 
mutants vary in the severity of their developmental defects. J Biol Chem. 
2004;279(15):15621-9. 
   31 
 
 
81. Parafati M, Lascala A, Morittu VM et al. Bergamot polyphenol fraction prevents 
nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat 
model of metabolic syndrome. J Nutr Biochem. 2015. 
82. Park HW, Lee JH. Calcium channel blockers as potential therapeutics for obesity-
associated autophagy defects and fatty liver pathologies. Autophagy. 2014;10(12):2385-6. 
83. Penna F, Baccino FM, Costelli P. Coming back: autophagy in cachexia. Curr Opin Clin 
Nutr Metab Care. 2014;17(3):241-6. 
84. Perfield JW, Ortinau LC, Pickering RT, Ruebel ML, Meers GM, Rector RS. Altered 
hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient 
Ob/Ob mice. J Obes. 2013;2013:296537. 
85. Pogozelski AR, Geng T, Li P et al. p38gamma mitogen-activated protein kinase is a key 
regulator in skeletal muscle metabolic adaptation in mice. PLoS One. 2009;4(11):e7934. 
86. Poole KE, Seija A, Eck K, Harris M, Nick TN, Wooten JS. The effects of physical 
activity on hepatic lipid metabolism during weight-loss. International Journal of Exercise 
Science: Conference Proceedings. 2015;2(7). 
87. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible 
coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92(6):829-
39. 
88. Rebollo A, Roglans N, Baena M et al. Liquid fructose downregulates Sirt1 expression 
and activity and impairs the oxidation of fatty acids in rat and human liver cells. Biochim 
Biophys Acta. 2014;1841(4):514-24. 
89. Rector RS, Thyfault JP, Uptergrove GM et al. Mitochondrial dysfunction precedes 
insulin resistance and hepatic steatosis and contributes to the natural history of non-
alcoholic fatty liver disease in an obese rodent model. J Hepatol. 2010;52(5):727-36. 
90. Rector RS, Uptergrove GM, Morris EM et al. Daily exercise vs. caloric restriction for 
prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am J Physiol 
Gastrointest Liver Physiol. 2011;300(5):G874-83. 
91. Rector S, Upergrove G, Morris M et al. Daily exercise vs. caloric restriction for 
prevention of nonalcoholic fatty liver Disease in the OLETF Rat Model. American 
Journal of Physiology Gastrointestinal and Liver Physiology. 2011:G874-G83. 
92. Reggiori F, Shintani T, Nair U, Klionsky DJ. Atg9 cycles between mitochondria and the 
pre-autophagosomal structure in yeasts. Autophagy. 2005;1(2):101-9. 
93. Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 
2015;313(22):2263-73. 
   32 
 
 
94. Sarraf SA, Raman M, Guarani-Pereira V et al. Landscape of the PARKIN-dependent 
ubiquitylome in response to mitochondrial depolarization. Nature. 2013;496(7445):372-
6. 
95. Sauvé V, Lilov A, Seirafi M et al. A Ubl/ubiquitin switch in the activation of Parkin. 
EMBO J. 2015;34(20):2492-505. 
96. Sin J, Andres AM, Taylor DJ et al. Mitophagy is required for mitochondrial biogenesis 
and myogenic differentiation of C2C12 myoblasts. Autophagy. 2015:0. 
97. Sinha RA, Farah BL, Singh BK et al. Caffeine stimulates hepatic lipid metabolism by the 
autophagy-lysosomal pathway in mice. Hepatology. 2014;59(4):1366-80. 
98. Sinha RA, Singh BK, Zhou J et al. Thyroid hormone induction of mitochondrial activity 
is coupled to mitophagy via ROS-AMPK-ULK1 signaling. Autophagy. 2015;11(8):1341-
57. 
99. Spengler EK, Loomba R. Recommendations for Diagnosis, Referral for Liver Biopsy, 
and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. 
Mayo Clin Proc. 2015. 
100. Swaney DL, Rodríguez-Mias RA, Villén J. Phosphorylation of ubiquitin at Ser65 affects 
its polymerization, targets, and proteome-wide turnover. EMBO Rep. 2015;16(9):1131-
44. 
101. Tu QQ, Zheng RY, Li J et al. Palmitic acid induces autophagy in hepatocytes via JNK2 
activation. Acta Pharmacol Sin. 2014;35(4):504-12. 
102. Wang L, Liu X, Nie J et al. ALCAT1 controls mitochondrial etiology of fatty liver 
diseases, linking defective mitophagy to steatosis. Hepatology. 2015;61(2):486-96. 
103. Wauer T, Simicek M, Schubert A, Komander D. Mechanism of phospho-ubiquitin-
induced PARKIN activation. Nature. 2015;524(7565):370-4. 
104. Wauer T, Swatek KN, Wagstaff JL et al. Ubiquitin Ser65 phosphorylation affects 
ubiquitin structure, chain assembly and hydrolysis. EMBO J. 2015;34(3):307-25. 
105. Wei X, Qi Y, Zhang X et al. ROS act as an upstream signal to mediate cadmium-induced 
mitophagy in mouse brain. Neurotoxicology. 2015;46:19-24. 
106. Xu J, Cao K, Li Y et al. Bitter gourd inhibits the development of obesity-associated fatty 
liver in C57BL/6 mice fed a high-fat diet. J Nutr. 2014;144(4):475-83. 
107. Yang L, Li P, Fu S, Calay ES, Hotamisligil GS. Defective hepatic autophagy in obesity 
promotes ER stress and causes insulin resistance. Cell Metab. 2010;11(6):467-78. 
108. Zhou L, Yu X, Meng Q et al. Resistin reduces mitochondria and induces hepatic steatosis 
in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha 
pathway. Hepatology. 2013;57(4):1384-93. 

















































Figure 1: Flow chart of PINK1/PARKIN and BNIP3 mediated pathways, 
green star indicates starting point  






























Figure 2: Flow chart of experimental protocol.    

















































Figure 3: Phenotypic data from current study. A: Body weights of animals. B: Liver 
weights of animals. C: Calories consumed per animal per week in the last 8 weeks 
of experiment. D: Food weight consumed per animal per week in the last 8 weeks of 
experiment. E: % lipid content in the livers of animals. F: Triglyceride levels in 
animals. G: Cholesterol levels in animals.  











Figure 4: Markers of mitochondrial biogenesis and content. A: PGC1-α protein content. B: 
COX-IV protein content. C: Representative blots for PGC1-α and COX-IV.  
Figure 5: BNIP3 mediated mitophagy. A: BNIP3 protein content. B: Representative blot of 
BNIP3. 









































Figure 6: PINK1/PARKIN mediated mitophagy data. A: PINK1 protein content. B: 
PARKIN protein content. C: p-PARKINSer56 protein content. D: p-PARKIN/PARKIN 
protein content. E: Ubiquitin (Ub) protein contend. F: p-UbSer65 protein content. G: 
Ratio of: p-Ub/Ub protein content. H: Representative blots for PINK1, PARKIN, P-
PARKIN, Ub, and p-Ub.  

















































Figure 7: Markers of macroautophagy. A: LC3II/I ratio. B: LC3II content. C: Total LC3 
content. D: p62 protein content. E: Representative blots for LC3 and p62.  



















Figure 8: AMPK activity. A: Total AMPK protein content. B: p-AMPKThr172 
protein content. C: p-AMPK/AMPK ratio. D: Representative images for AMPK 
and p-AMPKThr172. 
























Figure 9: Conclusions from this study. HFD does not appear to affect overall PINK1 
content or PARKIN activation, yet does appear to ramp up PINK1 activation via the 
phosphorylation of UbSer65, yet the total mitophagy process does not resolve itself, 
suggesting that HFD may decrease capacity for completing the mitophagy process. 
Further, HFD decreases cellular capacity for BNIP3 mediate mitophagy. Taken 
together, it appears HFD mitigates multiple pathways for mitophagy in the liver. 
D/PA had overall greater effects than D itself, D/PA appears to predominantly affect 
the BNIP3 mitophagy process. Compared to HFD animals, D/PA animals are capable 
of adequately completing PINK1/PARKIN mediated mitophagy, though in this group 
PINK1/PARKIN does not appear to be as active compared to BNIP3.  Taken together, 
this study suggests D/PA can restore aspects of mitophagy that become dysfunctional 
with prolonged HFD.   
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